APA (7th ed.) Citation

S, Z., X, X., F, C., Y, Y., N, Z., Y, C., . . . N, Z. (2024). COL5A2 drives regorafenib resistance-induced metastatic phenotype via reducing LIFR expression in hepatocellular carcinoma. Acta biochimica et biophysica Sinica, 56(7), 997. https://doi.org/10.3724/abbs.2024058

Chicago Style (17th ed.) Citation

S, Zhang, Xue X, Chen F, Yang Y, Zhang N, Chen Y, Wu W, Wang J, and Zheng N. "COL5A2 Drives Regorafenib Resistance-induced Metastatic Phenotype via Reducing LIFR Expression in Hepatocellular Carcinoma." Acta Biochimica Et Biophysica Sinica 56, no. 7 (2024): 997. https://doi.org/10.3724/abbs.2024058.

MLA (9th ed.) Citation

S, Zhang, et al. "COL5A2 Drives Regorafenib Resistance-induced Metastatic Phenotype via Reducing LIFR Expression in Hepatocellular Carcinoma." Acta Biochimica Et Biophysica Sinica, vol. 56, no. 7, 2024, p. 997, https://doi.org/10.3724/abbs.2024058.